Economics of Innovation

News
June 2020

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

Insight
May 2020

The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?

News
May 2020

Indication-Based Pricing: Are We All Onboard?

Past Event
April 2020

How Should the World Pay for a COVID-19 Vaccine?

News
April 2020

Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support

News
April 2020

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

News
March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

News
March 2020

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

News
March 2020

Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds

News
February 2020

Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation

News
February 2020

A Final MVAC Blueprint—and the Start of an R&D Revolution?

News
January 2020

OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?

Latest Research & Publications

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

2020 OHE Annual Report to the Charity Commission

It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?

Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations

Payment Models for Multi-Indication Therapies

All Publications

Filter results by

Filter results by

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?

Indication-Based Pricing: Are We All Onboard?

How Should the World Pay for a COVID-19 Vaccine?

Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Are Cost-Effectiveness Thresholds Fit for Purpose for Real-World Decision Making on Access to and Pricing of Pharmaceuticals? A New OHE Paper on Current Methods and Practices, and a Novel Approach for Optimal Thresholds

Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation

A Final MVAC Blueprint—and the Start of an R&D Revolution?

OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?

Share on Mastodon